|

Nivolumab and Relatlimab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Opdualag

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Wisconsin, Madison1

Indications

  • Liver Disease1
  • Liver Metastases1
  • Metastatic Melanoma1
  • Liver Cancer1
  • Cancer1

Madison, Wisconsin1 trial

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

UW Hospital and Clinics

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.